Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
23,8 USD | +3,16% | +4,02% | +10,13% |
Omzet 2024 * | 31,42 mln. 29,15 mln. | Omzet 2025 * | 121 mln. 113 mln. | Marktkapitalisatie | 2,02 mld. 1,88 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -312 mln. -289 mln. | Nettowinst (verlies) 2025 * | -251 mln. -233 mln. | EV/omzet 2024 * | 55,1 x |
Nettoliquiditeiten 2024 * | 291 mln. 270 mln. | Nettoliquiditeiten 2025 * | 223 mln. 207 mln. | EV/omzet 2025 * | 14,8 x |
K/w-verhouding 2024 * |
-6,37
x | K/w-verhouding 2025 * |
-8,61
x | Werknemers | 184 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 98,24% |
Recentste transcriptie over Syndax Pharmaceuticals, Inc.
1 dag | +3,16% | ||
1 week | +4,02% | ||
Lopende maand | +1,54% | ||
1 maand | -0,34% | ||
3 maanden | +10,24% | ||
6 maanden | +52,27% | ||
Lopend jaar | +10,13% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Michael Metzger
CEO | Chief Executive Officer | 53 | 05-05-15 |
Peter Ordentlich
FOU | Founder | 55 | 11-10-05 |
Neil Gallagher
PSD | President | - | 10-04-23 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Keith Katkin
BRD | Director/Board Member | 52 | 29-03-17 |
Dennis Podlesak
CHM | Chairman | 66 | 01-12-08 |
Pierre Legault
BRD | Director/Board Member | 63 | 04-01-17 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.12% | 0 M€ | 0,00% | - | |
0.12% | 0 M€ | 0,00% | - | |
0.08% | 2 M€ | -.--% |
Datum | Koers | Variatie | Volume |
---|---|---|---|
28-03-24 | 23,8 | +3,16% | 1 058 374 |
27-03-24 | 23,07 | +7,60% | 1 190 999 |
26-03-24 | 21,44 | -4,46% | 1 248 893 |
25-03-24 | 22,44 | -0,62% | 825 478 |
22-03-24 | 22,58 | -1,31% | 1 076 996 |
uitgestelde koers Nasdaq, 28 maart 2024 om 21:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+10,13% | 2,02 mld. | |
+9,30% | 46,03 mld. | |
+52,73% | 44,55 mld. | |
+7,15% | 40,8 mld. | |
-8,78% | 28,25 mld. | |
+18,68% | 27,71 mld. | |
-21,92% | 18,82 mld. | |
+14,62% | 13,91 mld. | |
+31,85% | 12,43 mld. | |
+4,47% | 10,81 mld. |